Abstract
The aims of this paper are threefold. First, to describe why it is becoming increasingly important to measure the effect of modern therapy on the quality of patients’ lives. Second, to explain briefly the economic techniques which are being developed to produce these measurements. And third, to describe the problems which exist at the present stage in the development of these new techniques. The conclusion will be that the measurement of quality of life during and after the clinical evaluation of a new medicine will become increasingly essential during the 1990s. However a great deal of economic research, in collaboration with clinicians and pharmaceutical physicians, is still necessary before current methods of measurement can be regarded as routine and reliable ‘instruments’ in the evaluation of new therapies.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Reference
Office of Health Economics. Progress Against Tuberculosis, London: Office of Health Economics, 1962.
Teeling Smith G, Wells N E J. The economic contribution of the industry in England and Wales. Pharm J 1985;235:178–9.
Office of Health Economics. Sickness Absence; a Review, London: Office of Health Economics, 1981.
Teeling Smith G. Measurement of Health, London: Office of Health Economics, 1985.
Buxton M J, et al. Costs and Benefits of the Heart Transplant Programme, London: Her Majesty’s Stationery Office, 1985.
Rosser R M. Issues of measurement in the design of health indicators. In: Culger A J ed. Health Indicators, London: Martin Robertson, 1983.
Rosser R M. A history of the development of health indicators. In: Teeling Smith G ed. Measuring the social benefits of medicine, London: Office of Health Economics, 1984.
Williams A. Economics of coronary artery bypass grafting. Br Med J 1985;291:326–9.
Cromie B W. The feet of clay of the double-blind trial. Lancet 1963;2:994–7.
Editor information
Editors and Affiliations
Copyright information
© 1988 The International Federation of Associations of Pharmaceutical Physicians
About this chapter
Cite this chapter
Smith, G.T. (1988). Quality of life. In: Burley, D., Haward, C., Mullinger, B. (eds) The Focus for Pharmaceutical Knowledge. Palgrave, London. https://doi.org/10.1007/978-1-349-09571-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-349-09571-1_1
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-09573-5
Online ISBN: 978-1-349-09571-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)